Organization

Air Force Military Medical University

8 clinical trials

2 abstracts

Abstract

Efficacy and safety of aumolertinib combined with or without chemotherapy as an adjuvant treatment for stage II-IIIA non-small cell lung cancer following complete tumour resection: The first third-generation EGFR-TKI versus chemotherapy phase III clinical study (APEX).

Org: Sichuan Provincial People's Hospital, Tianjin Chest Hospital, Air Force Military Medical University, The First Affiliated Hospital of Jilin University, The First People's Hospital of Yunnan Province,

Abstract

Envafolimab plus chemotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma (ESCC): A prospective, single-arm, phase II study.

Org: Department of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China, Department of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China, Guangzhou, China, Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China, Nanfang Hospital, Southern Medical University, Guangzhou, China, Tangdu Hospital, Air Force Military Medical University, Xi'an, China,

Clinical trial

Efficacy and Safety of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 Chronic Kidney Disease

Status: Recruiting, Estimated PCD: 2025-08-01

Clinical trial

Glutamine Combined With Thalidomide in Preventing Radiation-induced Oral Mucositis in Patients Undergoing radiotherapy-a Multicenter, Open-label, Randomized Controlled Study

Status: Not yet recruiting, Estimated PCD: 2024-08-31

Clinical trial

The Effect of 100mg Aspirin on Recurrent Acute Pancreatitis: a Prospective Cohort Study

Status: Recruiting, Estimated PCD: 2026-11-01

Clinical trial

Median Effective Dose (ED50) of Esketamine Combined With Alfentanil for Children to Inhibit Body Movement During Laser Treatment for Facial Lesion

Status: Not yet recruiting, Estimated PCD: 2025-03-27